Teva Pharmaceutical Settles With Oklahoma For $85 Million Over Opioid Claims
  • 5 years ago

Teva Pharmaceutical Industries Limited will pay an $85 million settlement with the state of Oklahoma. The news comes days before the Israel-based company was set to face trial over allegations that it and other drugmakers helped fuel the U.S. opioid epidemic. Teva is the world’s largest generic drugmaker, and says the settlement “does not establish any wrongdoing on the part of the company." According to Reuters, Teva denies contributing to opioid abuse in Oklahoma. Claims against Teva focused on the branded opioid products Actiq and Fentora as well as generic painkillers it produced.